Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Diisopropyl Ether | HCID 7914 | — |
| Reactant | Fesoterodine | HCID 6918558 | — |
| Reactant | HCID 90135091 | HCID 90135091 | — |
| Product | Fesoterodine fumarate | HCID 9849808 | — |
Reaction Steps
A 7% solution of aqueous NaHCO3 (25 ml) was added to a suspension of Fesoterodine Hydrochloride monohydrate (5 g) in dichloromethane (50 ml) at 10-15° C. The resulting mixture was stirred at room temperature and the two phases were separated. The organic phase was evaporated under reduced pressure; acetone (10 ml) was added twice and evaporated under reduced pressure to afford a Fesoterodine base solution. The Fesoterodine base solution was added over an acetone/fumaric acid suspension (10 ml/1.25 g) at 15-20° C. Diisopropyl ether 5 ml was added at 10-15° C. and the suspension was stirred to allow crystallization for 1-2 h, then diisopropyl ether 5 ml was added and the suspension stirred for 1-2 h. Finally diisopropyl ether (30 ml) was added and the suspension stirred for another 1-2 h. The suspension was filtered off and the crystallized product was washed with acetone/diisopropyl ether (10 ml), to yield 5.1 g of the corresponding Fesoterodine Fumarate.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09422228B2 |
|---|
| Source dataset | uspto-grants-2016_08 |
|---|
| ORD ID | ord-9eb7df8f1d084cd7a71067f46de8f0bd |
|---|
| Source note | uspto-grants-2016_08 |
|---|